Lulikeep Cream contains Luliconazole 1% w/w, an imidazole antifungal agent effective against a broad spectrum of dermatophytes, yeasts, and molds. It is primarily indicated for the topical treatment of superficial fungal infections such as tinea corporis, tinea cruris, tinea pedis, and cutaneous candidiasis. Luliconazole exerts its antifungal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation allows for targeted application to affected skin areas, promoting rapid relief of symptoms such as itching, redness, and scaling. Lulikeep Cream is generally well tolerated, with minimal local adverse effects including mild burning or irritation at the site of application. It should be applied once daily to the clean, dry affected area and surrounding skin, typically for a duration of 2 to 4 weeks depending on the infection type and clinical response. Patients are advised to avoid contact with eyes and mucous membranes. Use during pregnancy and lactation should be under medical supervision. Lulikeep Cream offers an effective and convenient option for managing superficial fungal infections, improving patient compliance and treatment outcomes.